Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
LipoKnoxa™ Human PPARGC1A shRNA Ad5 Particle (Silencing)
Cat. No.:
V0126XX62
Species:
Human
Target Gene:
PPARGC1A
Vector System:
Adenovirus
Modulation Type:
Silencing (shRNA)
SPECIFIC INQUIRY
Add to basket
| Sub Cat. No. | TargetSeq | Region | Inquiry |
|---|---|---|---|
| V0126XX62-1 | GACTATTGCCAGTCAATTAAT | CDS | Inquiry |
| V0126XX62-2 | TATGACAGCTACGAGGAATAT | CDS | Inquiry |
| V0126XX62-3 | TTCCATGAAGACACGCTTAAA | 3' UTR | Inquiry |
| V0126XX62-4 | Other | Inquiry |
Product Overview
Description:
LipoKnoxa™ Human PPARGC1A shRNA Ad5 Particle (Silencing) enables the targeted inhibition of PGC-1α, the master regulator of mitochondrial biogenesis and thermogenesis. This advanced RNAi tool is critical for studying metabolic flexibility and energy expenditure. We ensure a high-performing gene-silencing solution via thorough QC validation, including functional titer verification and negative results for sterility and mycoplasma, ensuring the highest level of biosafety.
Production Cell Line:
HEK293
Viral Backbone:
Adenovirus type 5 (dE1/E3)
Promoter:
U6; CMV; EF1α; CAG; UBC
Product Availability:
Produced Upon Order
Specification
Titer Test:
qPCR
Insert Verification:
All viral preparations are validated via Sequencing and PCR to ensure 100% sequence identity and the structural integrity of the vector genomes.
Sterility Test:
This product has been certified sterile following comprehensive microbial growth analysis, confirming the absence of bacterial and fungal contamination.
Mycoplasma Test:
This product was certified negative for mycoplasma contamination following stringent QC analysis, ensuring the absence of all mycoplasmal agents.
Other QC:
Beyond standard protocols, we offer customized knockdown efficiency validation through in vitro and in vivo assessments. This includes precise analysis of mRNA/protein reduction and subsequent biological responses to ensure the functional potency of the shRNA-mediated gene silencing.
Storage:
Upon receipt, viral preparations should be immediately transferred to -80°C for long-term storage to ensure maximum stability and maintain product integrity.
Stability:
This product maintains excellent biological activity for 6–12 months (and up to 2 years in specific cases) when stored continuously at -80°C. Once thawed, the working solution remains stable for 2–3 weeks at 4°C without significant loss of viral potency.
Shipping Condition:
All viral preparations are shipped on dry ice to ensure maximum biological activity and stability during transit.
Handling Notes:
Viral particles are susceptible to temperature fluctuations and freeze-thaw cycles. To preserve functional titers, it is essential to aliquot the vector into low-protein-binding tubes immediately upon first thaw. To ensure experimental success and biological safety, all procedures must be conducted within a certified biosafety cabinet.
Intended Use:
This product is intended for research use only and is not for use in diagnosis or therapeutic applications.
Product Disclaimer:
While our products are committed to excellence through rigorous internal QC inspections, we cannot guarantee specific performance or experimental outcomes due to the inherent complexity of biological systems. Users assume full responsibility for product storage, handling, and strict compliance with all applicable safety protocols, biosafety requirements, and legal regulations during all operational processes.
Target Profile
Gene Name:
PPARGC1A
Full Name:
PPARG coactivator 1 alpha
Gene Symbol:
LEM6; PGC1; PGC1A; PGC-1v; PPARGC1; PGC-1alpha; PGC-1(alpha)
Gene ID:
10891
RefSeq ID-1:
NP_001317680.1
RefSeq ID-2:
NM_001330751.2
Summary:
PPARGC1A encodes a transcriptional coactivator that plays a central role in the regulation of cellular energy metabolism. It interacts with multiple transcription factors, including PPARγ, CREB, and nuclear respiratory factors, thereby coordinating mitochondrial biogenesis and oxidative metabolism. By linking environmental and physiological cues to metabolic gene expression, this protein influences muscle fiber composition, lipid utilization, and thermogenesis. Dysregulation of PPARGC1A activity has been implicated in metabolic disorders, including obesity and insulin resistance.
Related Products
-
AdipoUpX™ Human ACSL1 Ad5 Particle (Overexpression)
-
LipoKnoxa™ Human ADCY3 shRNA Ad5 Particle (Silencing)
-
AdipoUpX™ Human LZTFL1 Ad5 Particle (Overexpression)
-
AdipoUpX™ Human MYT1L Ad5 Particle (Overexpression)
-
LipoKnoxa™ Human NR3C1 shRNA Ad5 Particle (Silencing)
-
AdipoUpX™ Human BBS12 Ad5 Particle (Overexpression)